Tiazotic acid

Tiazotic acid (brand names Thiotriazoline and Tiokor) is an antioxidant. It is used as a pharmaceutical drug for the treatment of ischemic heart disease in Russia, Ukraine, and Uzbekistan.^[1][2]

Tiazotic acid

Clinical data
Trade names	Thiotriazoline; Tiokor
Identifiers
IUPAC name 2-[(5-Methyl-1H-1,2,4-triazol-3-yl)sulfanyl]acetic acid
CAS Number	64679-65-8 357172-63-5 (morpholine salt)
PubChem CID	254566
UNII	YEZ00M9XKN
KEGG	D10852
ChEMBL	ChEMBL1487672
CompTox Dashboard (EPA)	DTXSID40214967
ECHA InfoCard	100.244.688
Chemical and physical data
Formula	C5H7N3O2S
Molar mass	173.19 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1=NC(=NN1)SCC(=O)O
InChI InChI=InChI=1S/C5H7N3O2S/c1-3-6-5(8-7-3)11-2-4(9)10/h2H2,1H3,(H,9,10)(H,6,7,8) Key:OJUNWHNRDPRNBR-UHFFFAOYSA-N

It is used as its salt with morpholine.^[3]

It has been studied for its potential to improve the cardiac effects of COVID-19.^[4]